By complying with the HRC’s controversial demands, Boehringer increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Boehringer uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Boehringer supports the Equality Act. The company opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Boehringer Ingelheim receives a High Risk rating.